Free prostate specific antigen (fPSA) detection kit (chemiluminescence immune analysis method) - NMPA Registration 国械注准20223401452
Access comprehensive regulatory information for Free prostate specific antigen (fPSA) detection kit (chemiluminescence immune analysis method) in the China medical device market through Pure Global AI's free database. This Class III medical device is registered under NMPA registration number 国械注准20223401452 and owned by Rayto Life and Analytical Sciences Co., Ltd.. The device was approved on November 02, 2022.
This page provides complete registration details including registrant information, province location (Guangdong), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.
It is suitable for the quantitative determination of the content of free prostate-specific antigen (fPSA) in human serum or plasma in vitro, mainly used for dynamic monitoring of patients with malignant tumors to assist in judging the disease process or treatment effect, and cannot be used as the basis for early diagnosis or diagnosis of malignant tumors, and cannot be used for tumor screening in the general population.
适用于体外定量测定人血清或血浆中游离前列腺特异性抗原（fPSA）的含量，主要用于对恶性肿瘤患者进行动态监测以辅助判断疾病进程或治疗效果，不能作为恶性肿瘤早期诊断或确诊的依据，不能用于普通人群的肿瘤筛查。
The kit consists of immunomagnetic beads (M), enzyme conjugates (R), calibrator 1 (optional), calibrator 2 (optional), control 1 (optional), and control 2 (optional). (Please refer to the product manual for details)
试剂盒由免疫磁珠（M）、酶结合物（R）、校准品1（选配）、校准品2（选配）、质控品1（选配）、质控品2（选配）组成。（具体信息详见产品说明书）
This product is stored at 2 °C ~ 8 °C and is valid for 12 months.
本产品在2℃～8℃保存，有效期为12个月。